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H ookah (waterpipe) smoking is a new global tobacco epidemic among youth.
1,2 Until recently, hookah was an ancient practice confined to Middle Eastern male culture. 3 In the 1990s, introduction of fruit-flavored prepackaged hookah tobacco products ignited a sharp uptake of hookah smoking by young women and men in the Middle East. 3 Then, hookah smoking was effectively marketed to youth in North America and Europe as a harmless alternative to cigarettes. [3] [4] [5] The prevalence of current hookah use is estimated to be up to 37% among students 13 to 15 years of age in Eastern Mediterranean and Eastern European countries, 6 and 15% to 25% among university students in the United States and United Kingdom, [7] [8] [9] where twice as many secondary school children smoke hookah as cigarettes 10, 11 and more adults have tried or currently use hookah than electronic cigarettes. 12, 13 Currently in the United States, nationally representative data show that, among adults 18 to 24 years of age, 18.2% reported current (past 30 days) hookah use, in comparison with 19 .6% who reported cigarette use, whereas e-cigarette use was reported by 8.9%. 14 Although cigarette smoking acutely impairs endothelial function, 15 the effect of smoking fruit-flavored hookah tobacco is unknown. Because charcoal briquettes traditionally are used to heat the hookah tobacco in the waterpipe, hookah smoke delivers tobacco toxicants and nicotine plus charcoal combustion products: not only carbon-rich nanoparticles and other oxidants that may destroy nitric oxide and impair endothelial function, but also large amounts of carbon monoxide (CO), a putative vasodilator molecule.
To determine the net acute effect of hookah smoking on endothelial function, we measured plasma nicotine, exhaled CO, and brachial artery flow-mediated dilation (FMD) before and after young adult hookah smokers smoked traditional charcoal-heated hookah. To remove the effect of charcoal combustion products, the same measurements were performed when the same hookah flavored tobacco product was heated electrically. The acute FMD response to cigarette smoking in age-matched cigarette smokers served as a positive internal control. Finally, to isolate the effect of acute CO exposure, we compared FMD responses to smoking charcoal-heated hookah with those seen when the same hookah smokers inhaled a 0.1% CO gas mixture to match their hookah-induced CO boost. We hypothesized that CO, a key charcoal combustion product in hookah smoke, masks acute hookah tobacco-induced impairment in endothelial function.
METHODS
The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure. The data are available from the corresponding author on reasonable request.
The study protocol was approved by the Institutional Review Boards at both Cedars-Sinai Medical Center and the University of California, Los Angeles. All subjects provided their informed written consent to participate. Hookah smokers who do not smoke cigarettes or cigarette smokers (who may or may not smoke hookah) 18 to 34 years of age were recruited by advertisement (college campuses, local media) and screened for eligibility with a medical and smoking history, physical examination, and 12-lead ECG. For CO gas inhalation experiments, smokers were additionally screened with venous blood sampling to assess complete blood count, lipid profile, glucose levels, and liver function and urine toxicology for opiate, cocaine, amphetamine, barbiturates, phencyclidine, methadone, benzodiazepine, and propoxyphene. Inclusion criteria for hookah smokers were as follows: smoked hookah ≥12 times in the past 12 months and never tried cigarettes; for cigarette smokers: smoked ≥5 cigarettes per day for ≥4 years (ie, at least 1 pack-year). Exclusion criteria included: history of diabetes mellitus, dyslipidemia, hypertension, or illicit drug use; body mass index ≥30 kg/m 2 , resting heart rate ≥100/min; resting blood pressure ≥140/90 mm Hg, or any other physical evidence of cardiopulmonary disease; rhythm other than sinus on ECG; positive pregnancy test; any prescription medication or antioxidant vitamin supplementations; presmoking exhaled CO ≥10 ppm (indicating nonabstinence); or psychiatric illness. For CO gas inhalation experiments, additional exclusion criteria included anemia, hyperlipidemia, elevated blood glucose, elevated liver function tests, or positive toxicology.
All subjects agreed to abstain from exercise, alcohol, and caffeine for 24 hours before the study. Testing was performed at 0800 hours after overnight fast and overnight nicotine abstinence. Subjects were instructed not to smoke hookah for ≥24 hours or cigarettes for ≥8 hours before the study, with compliance checked by exhaled CO. Women were tested
Clinical Perspective
What Is New?
• Although hookah smoking is marketed as a harmless alternative to cigarettes, our study demonstrates that smoking hookah tobacco, similar to cigarette tobacco, acutely impairs endothelial function.
• With traditional charcoal-heated hookah smoking, the acute endothelial dysfunction is masked by high levels of carbon monoxide, a vasodilator molecule generated by charcoal combustion.
What Are the Clinical Implications?
• As functional impairment of the endothelium is one of the earliest signs of development of acute and chronic atherosclerotic cardiovascular disease, the new data show that, although the effects of hookah smoking on the endothelium are complex, smoking hookah is not a harmless alternative to cigarettes.
during the follicular phase of their menstrual cycles to avoid the luteal dip in FMD.
Measurement of Brachial Artery FMD
Brachial artery FMD was performed in strict accordance with current standards shown to optimize test-retest reproducibility. 16 In brief, with the subject supine and the left arm abducted at heart level, the brachial artery (3-7 cm above the antecubital crease) was imaged using a 5-to 12-MHz linear array transducer attached to a high-resolution ultrasound machine (Toshiba, Xario XG 2000). To ensure the location of the same arterial segment after each smoking session, anatomic landmarks were noted and the distance from the antecubital crease was recorded. A rapid-inflation/deflation pneumatic cuff (Hokanson) was placed on the upper forearm, distal to the imaged artery, for 5 minutes and inflated to suprasystolic pressure (250 mm Hg). Doppler velocity was measured continuously with a fixed insonation angle of 60°, using a stereotaxic instrument to stabilize probe position.
Baseline diameter and velocity were recorded for 45 seconds and resumed 30 seconds before cuff deflation and continuously for 2 minutes after deflation to obtain peak vasodilatory response. Recordings were triggered and captured at the R wave of the ECG (end-diastolic diameter) using AccuSync 72 ECG trigger monitor and stored for offline analysis using validated edge-detection software (Brachial Analyzer for Research, Medical Imaging Applications, LLC).
FMD measurements were calculated as absolute and percent change in brachial artery diameter. 17 Peak hyperemic shear rate was calculated as (8 × time-averaged peak velocity)/occlusion diameter, based on a wide centered sample volume from the first 15 velocity envelopes following cuff release. 17 Because the main stimulus for FMD is an acute increase in hyperemic shear stress, to account for potential differences in peak hyperemic shear rate between conditions, FMD values were also normalized for the magnitude of the hyperemic stimulus (ie, change in diameter divided by the hyperemic shear rate). 18 Records were coded with all individual identifiers removed such that data were analyzed by 2 experienced study investigators (and) who were blinded to subject identity and to experimental condition (preintervention baseline, charcoal-heated or electrically heated hookah, cigarette smoking, or CO gas inhalation).
Exposure Biomarkers
Before and after each experimental session, end-expired CO was measured by CO meter (Micro Smokerlyzer, Bedfont Scientific Ltd) and plasma nicotine was assayed by gas chromatography. 19 For CO gas inhalation experiments, endexpired CO and carboxyhemoglobin levels were collected before, during, and after each experimental session.
Experimental Studies
All study sessions were conducted with subjects seated comfortably in a custom-built smoking chamber in which fresh air continuously circulates through a vent in the ceiling (Figure 1) , as described previously. 20 Air-tight rubber ports allowed wires and tubing to be connected to recording equipment outside the closed chamber. Blood pressure was measured continuously with a validated oscillometric sphygmomanometer (Mindray Accutor V). Heart rate was measured continuously by a cardiotachometer triggered by the R wave of the ECG recorded/displayed in real time (PowerLabADInstruments).
Experimental Protocols

Protocol 1: Responses to Smoking Traditional Charcoal-Heated Hookah
To determine the net acute effect on FMD of smoking traditional charcoal-heated hookah tobacco, we measured exhaled CO, plasma nicotine, and brachial artery FMD before and after 30 minutes of ad libitum hookah smoking in 30 subjects. Using a traditional waterpipe, subjects smoked 12 g of the most popular brand of maassel (5%-10% tobacco fermented with molasses, fruit, and glycerin; Starbuzz Tobacco, Inc) heated with charcoal briquettes (Coco Nara 100% Natural Coal; Figure 1 ).
Protocol 2: Responses to Smoking Hookah Tobacco Without Charcoal
To dissect out the effect of hookah tobacco toxicants alone, without charcoal combustion, we replaced the charcoal briquettes with an electronic heating element (Global First Electronic Shisha Charcoal termed e-coal; Figure 1 ). Twenty subjects participated in this protocol (10 of which also participated in protocol 1), and measurements were repeated before and after smoking the same fruit-flavored hookah tobacco heated with e-coal.
Protocol 3: Responses to Smoking Cigarettes
Cigarette smokers (n=15), matched exactly on age, smoked 1 cigarette (Camel Filtered, ≈0.7 g of tobacco) down to the filter overwrap in ≤10 minutes, as a positive internal vasoconstrictor control.
Protocol 4: Responses to Inhaled 0.1% CO Alone Without Tobacco
To isolate the mechanistic role of CO on the FMD response to smoking charcoal-heated hookah, we repeated the measurements before and after a subset of hookah smokers (n=8) inhaled a carefully controlled 0.1% CO gas mixture for 30 minutes to approximate their CO boost derived from smoking charcoal-heated hookah. Smokers were asked to intermittently inhale CO gas mixture from a nondiffusing 1-L Douglas bag twice every minute for 30 minutes punctuated every 5 minutes with 1-minute stops to check exhaled CO and draw venous blood to conduct off-line measurements of carboxyhemoglobin.
Time-Control Experiments and Test-Retest Reproducibility of FMD
Measurements were repeated before and after a subset of 5 hookah smokers sat in the smoking chamber for 30 minutes breathing room air without smoking and without CO gas exposure. To further document within-subject test-retest reproducibility of FMD indexes in the absence of smoking or CO inhalation, we measured FMD on both arms twice (total of 4 scans) with 20 minutes between each scan.
Statistical Analysis
All results are reported as mean±SE unless otherwise specified. Statistical analyses were performed using SAS (version 9.4). For each of the 3 forms of individual smoking, we tested pre-versus postsmoking changes using paired t tests. We also
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applied paired t tests to compare the pre-versus postchanges induced by 0.1% CO versus charcoal-heated hookah. To assess test-retest reproducibility, we performed ordinary least products regression, calculation of intraclass correlation coefficient, 21 and Bland-Altman analyses. Statistical significance was set at the 0.05 level.
RESULTS
Subject Enrollment and Characteristics
We screened a total of 69 hookah smokers and 31 cigarette smokers. The first subject was enrolled in June 2015 and the last subject completed the study in June 2018. Twenty-five hookah smokers were excluded for the following reasons: history of cigarette smoking and illicit drug use (n=13); medical history of obesity, asthma, or diabetes mellitus (n=8); and exhaled CO >10 ppm on screening (nonabstinence, n=4). Because of limb movement during image acquisition resulting in poor data quality, 4 subjects were excluded from analysis. Fourteen cigarette smokers were excluded for history of illicit drug use (n=2); obesity, asthma, or diabetes mellitus (n=2); and infrequent cigarette smoking (n=10). Two subjects were excluded because of inadequate data collection (n=2). For the 0.1% CO protocol, 7 subjects were excluded for the following reasons: elevated liver function tests (n=2), hyperlipidemia (n=1), and positive toxicology (n=2). Because of limb movement during image acquisition resulting in poor data quality, 2 subjects were excluded from analysis. 
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We studied a total of 40 young adult hookah smokers. Thirty subjects completed protocol 1 (charcoal-heated hookah), 20 subjects (10 of which also participated in protocol 1) completed protocol 2 (electrically heated hookah), and 8 subjects (all of which have participated in protocol 1) completed protocol 4 (0.1% CO). In addition, 15 cigarette smokers completed protocol 3 (cigarette smoking).
The characteristics of the hookah smokers and cigarette smokers are shown in Table 1 . The characteristics of the subsets of hookah smokers who completed protocols 2 and 4 are shown in Table I in the online-only Data Supplement. By design, cigarette smokers were well matched with the hookah smokers on age, sex, race/ethnicity, body mass index, and educational attainment. Hookah smokers reported smoking hookah on average 2 times per week, with each session lasting on average 96 minutes (range, 60-120 minutes), whereas cigarette smokers were mostly light smokers (ie, smoked <1 pack per day). Ten of the 15 cigarette smokers were dual users who also smoked hookah.
Comparative Effects of the Different Forms of Smoking on Exposure Biomarkers, Brachial Artery FMD, and Systemic Hemodynamics
The comparative acute effects of the different forms of smoking are shown in Table 2 and Figure 2 . All 3 types of smoking acutely increased plasma nicotine levels. The CO boost was 9.5-fold greater after smoking charcoal-heated hookah than after smoking electrically heated hookah and 8.7-fold greater after cigarette smoking: +24±2 versus +3±1 versus +3±1 ppm, respectively (P<0.001).
Brachial artery FMD did not decrease but rather increased by +43±6% (P<0.001) after smoking charcoalheated hookah tobacco. In contrast, FMD decreased by -27±4% (P<0.001) after smoking the same hookah tobacco heated electrically; the latter was comparable to the acute -36±4% (P<0.001) decrease induced by cigarette smoking, which is consistent with prior reports. 15, 22 FMD changes remained significant across all 3 smoking conditions after normalizing FMD to shear rate (P<0.001 for all conditions).
Both forms of hookah smoking produced increases in blood pressure and heart rate that were smaller than those seen with cigarette smoking (Table II in 
Comparative Effects of 0.1% CO Versus Charcoal-Heated Hookah
The detailed clinical characteristics and baseline hemodynamics of the subset of hookah smokers who participated in the 0.1% CO protocol are shown in Table III in the online-only Data Supplement.
By design, increases in exhaled CO achieved after inhaling 0.1% CO gas closely approximated those achieved after these subjects smoked charcoal-heated hookah (+24±1 versus +28±3 ppm, CO gas versus hookah; Table 3 and Figure 3 ). Despite similar increases in exhaled CO, the increase in FMD was 2.8 times greater with 0.1% CO gas than with charcoal-heated hookah: +139±4% versus +49±6% (P<0.001; Table 3 and Figure 3) . Unlike hookah smoking, inhaling 0.1% CO had no effect on systemic hemodynamics (Table IV in 
Time-Control Experiments and TestRetest Reproducibility of FMD
Sitting in the smoking chamber for 30 minutes, without smoking, had no effect on any of the parameters mea- Data are reported as number (n) or mean±SD. *Data are reported as median (interquartile range). †Summary data from 10 cigarette smokers who also smoke hookah (dual users). (Table VI in 
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DISCUSSION
Much more is known about the toxicology of hookah smoke than about the effects of hookah smoking on human cardiovascular physiology. 23 Hookah smoke delivers a complex mixture of tobacco toxicants and charcoal combustion products that could exert differential acute effects on endothelial function. The major new findings from this study of overtly healthy young adult hookah smokers are as follows. Brachial artery FMD, a well-established index of endothelial function, increased after smoking hookah tobacco heated with charcoal but decreased, as with cigarette smoking, when the same tobacco product was heated electrically. Moreover, FMD increased markedly when hookah smokers breathed a 0.1% CO gas mixture. For comparable CO boosts in the same subjects, the increase in FMD was far less with charcoal-heated hookah than with 0.1% CO. Taken together, these data indicate that, in young adult hookah smokers, CO, a charcoal combustion product, masks an otherwise deleterious acute effect of hookah tobacco toxicants on brachial artery endothelial function.
Our FMD data counter social media advertisements that trivialize or ignore potential health risks associated with hookah smoking. That FMD decreased to the same extent after smoking electrically heated hookah tobacco as after cigarette smoking challenges claims that sweetened prepackaged hookah tobacco, touted as comprising mainly molasses and dried fruit, is a harmless alternative to cigarette tobacco. 3, 4 That FMD decreased when hookah tobacco was heated electrically but increased when the same tobacco product was heated with charcoal challenges advertising claims that the electronic heating element we used (marketed as e-coal) produces the healthiest form of hookah smoking. Rather, smoking hookah tobacco heated with e-coal triggers a similar acute decrement in brachial artery FMD as shown previously with every other tobacco product and nicotine delivery system including tobacco cigarettes (both mainstream and second-hand smoke), 15, 22, 24 snuff, 25 cigars and cigarillos, 26 medicinal nicotine, 22 and, most recently, electronic cigarettes.
27
A seminal finding of our study is that acute CO exposure constitutes a potent vasodilator stimulus. That FMD increased markedly after breathing a 0.1% CO gas mixture, which mimics the CO boost produced by smoking charcoal-heated hookah, strongly suggests that CO is the key vasodilator molecule in hookah smoke. Because the increase in FMD with charcoal-heated hookah was only one-third the magnitude of the increase seen with 0.1% CO gas, we conclude that the hookah-induced increase in FMD constitutes a relative attenuation.
There is precedent for CO being a vasodilator molecule. Drugs that upregulate the endogenous production of CO by heme oxygenase are being developed to treat vascular disease. 28 In isolated vascular rings, 
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exogenous CO causes cGMP-dependent vasodilation, and, in intact animals, CO releases nitric oxide and augments nitric oxide-dependent vasodilation. 30, 31 In pregnant women, repeated CO exposure from cigarette smoking is associated with a paradoxically reduced risk of preeclampsia (associated with pathological vasoconstriction) in comparison with both nonsmokers or users of smokeless tobacco (snuff) which does not generate CO. 32 Our data confirm and extend these various lines of previous work by showing that the level of acute CO exposure routinely produced by hookah smoking is a potent stimulus to human brachial artery FMD. That hyperemic response, an index of microvascular function, 33 increased after acute CO exposure suggests that CO exposure also dilates arterioles in the microvasculature, as has been demonstrated in animals. 31 FMD is an established marker of endothelial function. 34 Impaired endothelial function is characterized not only by impairment in vasomotor response (reduced endothelial-dependent vasodilation), but also by enhanced vascular permeability, enhanced cell proliferation, and impaired antiplatelet and anti-inflammatory functions. 35 Thus, we speculate that, although CO may mask acute effects of charcoal-heated hookah smoking on flow-mediated vasodilation, it may not mask other associated aspects of impaired vascular function, which may promote acute and chronic cardiovascular diseases. Because both hookah and cigarettes are vehicles for tobacco, and chronic cigarette smoking is associated with impaired endothelial function, 36, 37 the acute effects of hookah smoking may not be more benign than cigarette smoking with chronic use. It is possible that the effects of CO dissipate more quickly than the effects of the tobacco smoke on endothelial function, such that, with chronic hookah smoking, the predominant effect is the same as with cigarette smoking.
Our study has several limitations. For ethical reasons, condition assignment was not random to avoid introducing hookah-only smokers to cigarettes. However, the observed decrease in FMD with cigarette smoking was quite consistent with prior reports. 15, 22 For the 0.1% CO experiments, randomization and blinding were impossible during data collection, but off-line analyses for all our studies were conducted by blinded evaluators. With subjects smoking individually in our vented chamber, the shorter smoking duration and lack of side-stream and second-hand smoke may have underestimated their hookah exposure in the social setting of a hookah café. The mean CO boost after hookah smoking in our study falls within the lower range seen in other studies of ad libitum hookah smoking in both an inpatient clinical research center 38 and actual hookah cafés. 39 Although we studied the most popular brand of hookah tobacco and charcoal briquettes, our data cannot be extrapolated to the multitude of unregulated hookah products. ORIGINAL RESEARCH ARTICLE Because our present acute exposure studies focused solely on the brachial artery, we believe that future studies are needed to investigate the acute and chronic effects of hookah smoking on vascular beds that are more prone to atherosclerosis. Because CO exposure reduces hemoglobin oxygen-carrying capacity, as a compensatory response to relative hypoxemia, chronic CO exposure results in polycythemia, 40 and is believed to contribute to hypercoagulability in smokers.
In conclusion, in overtly healthy young adult hookah smokers, CO is a key charcoal combustion product that masks an otherwise deleterious effect of hookah smoking on brachial artery FMD. With respect to large-artery endothelial function, smoking hookah is not a harmless alternative to smoking cigarettes. 
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